Electrophysiological and cerebrovascular effects of the α-secretase-derived form of amyloid precursor protein in young and middle-aged rats

Brain Research

Volumn 1131, Issue 1, 2007, Pages 112-117

  Sánchez Alavez, Manuel ^a   Chan, Sic L ^b   Mattson, Mark P ^b   Criado, José R ^a,c  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c SCRIPPS CLINIC   (United States)

Author keywords

Aging; Alzheimer's disease; Blood flow; EEG; Hippocampus; sAPP

Indexed keywords

ALPHA SECRETASE; AMYLOID PRECURSOR PROTEIN; RECOMBINANT PROTEIN;

AGING; ANIMAL EXPERIMENT; ARTICLE; BRAIN BLOOD FLOW; BRAIN BLOOD VESSEL; BRAIN CORTEX; BRAIN ELECTROPHYSIOLOGY; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; HIPPOCAMPUS; LONG EVANS RAT; MALE; NERVE CELL PLASTICITY; NEUROPHYSIOLOGY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RAT;

AGING; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; BRAIN; CEREBRAL ARTERIES; CEREBRAL CORTEX; CEREBROVASCULAR CIRCULATION; DEMENTIA; DISEASE MODELS, ANIMAL; ELECTROENCEPHALOGRAPHY; HIPPOCAMPUS; INJECTIONS, INTRAVENTRICULAR; MALE; MEMORY DISORDERS; NEUROPROTECTIVE AGENTS; RATS; RATS, LONG-EVANS; RECOMBINANT FUSION PROTEINS; VASODILATION;

RATTUS;

EID: 33846019298     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.10.074     Document Type: Article

References (39)

1. Anderson J.J., Holtz G., Baskin P.P., Wang R., Mazzarelli L., Wagner S.L., and Menzaghi F. Reduced cerebrospinal fluid levels of alpha-secretase-cleaved amyloid precursor protein in aged rats: correlation with spatial memory deficits. Neuroscience 93 (1999) 1409-1420
2. Avery E.E., Baker L.D., and Asthana S. Potential role of muscarinic agonists in Alzheimer's disease. Drugs Aging 11 (1997) 450-459
3. Beach T., Kuo Y., Schwab C., Walker D., and Roher A. Reduction of cortical amyloid beta levels in guinea pig brain after systemic administration of physostigmine. Neurosci. Lett. 310 (2001) 21-24
4. Benzi G., and Moretti A. Is there a rationale for the use of acetylcholinesterase inhibitors in the therapy of Alzheimer's disease?. Eur. J. Pharmacol. 346 (1998) 1-13
5. Bizon J., and Gallagher M. Production of new cells in the rat dentate gyrus over the lifespan: relation to cognitive decline. Eur. J. Neurosci. 18 (2003) 215-219
6. 1-42/1-40 ration in vitro and in vivo. Neuron 17 (1996) 1005-1013
7. Buckner R. Memory and executive function in aging and AD: multiple factors that cause decline and reserve factors that compensate. Neuron 44 (2004) 195-208
8. Crook T., Bartus R., Ferris S., Whitehouse P., Cohen G., and Gershon S. Age-associated memory impairment: proposed diagnostic criteria and measures of clinical change. Report of a National Institute of Mental Health Work Group. Dev. Neuropsychol. 2 (1986) 261-276
9. Cummings J.L., and Mendez M.F. Alzheimer's disease: cognitive and behavioral pharmacotherapy. Conn. Med. 61 (1997) 543-552
10. Cummings J.L., Vinters H.V., Cole G.M., and Khachaturian Z.S. Alzheimer's disease: etiologies, pathophysiology, cognitive reserve, and treatment opportunities. Neurology 51 (1998) S2-S17
11. Dirnagl U., Kaplan B., Jacewicz M., and Pulsinelli W. Continuous measurement of cerebral cortical blood flow by laser-Doppler flowmetry in a rat stroke model. J. Cereb. Blood Flow Metab. 9 (1989) 589-596
12. Fadel J., Sarter M., and Bruno J. Age-related attenuation of stimulated cortical acetylcholine release in basal forebrain-lesioned rats. Neuroscience 90 (1999) 793-802
13. Furukawa K., and Mattson M.P. Secreted amyloid precursor protein alpha selectively suppresses N-methyl-d-aspartate currents in hippocampal neurons: involvement of cyclic GMP. Neuroscience 83 (1998) 429-438
14. Furukawa K., Barger S.W., Blalock E.M., and Mattson M.P. Activation of K+ channels and suppression of neuronal activity by secreted beta-amyloid-precursor protein. Nature 379 (1996) 74-78
15. Gaillard J. Neurotransmitters and sleep pharmacology. In: Thorphy M. (Ed). Handbook of Sleep Disorders (1990), Marcel Dekker, New York 55-76
16. Givens B., and Sarter M. Modulation of cognitive processes by trans-synaptic activation of the basal forebrain. Behav. Brain Res. 84 (1997) 1-22
17. Glenner G.G., and Wong C.W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120 (1984) 885-890
18. Herzog C., Nowak K., Sarter M., and Bruno J. Microdialysis without acetylcholinesterase inhibition reveals an age-related attenuation in stimulated cortical acetylcholine release. Neurobiol. Aging. 24 (2003) 861-863
19. Iadecola C., and Reis D.J. Continuous monitoring of cerebrocortical blood flow during stimulation of the cerebellar fastigial nucleus: a study by laser-Doppler flowmetry. J. Cereb. Blood Flow Metab. 10 (1990) 608-617
20. Jones B. Activity, modulation and role of basal forebrain cholinergic neurons innervating the cerebral cortex. Prog. Brain Res. 145 (2004) 157-169
21. Kral V. Benign sensecent forgetfulness. In: Katzman R., Terry R., and Bick K. (Eds). Alzheimer's Disease, Senile Dementia and Related Disorders (1977), Raven Press, New York 47-51
22. Levine E., Dreyfus C., Black I., and Plummer M. Brain-derived neurotrophic factor rapidly enhances synaptic transmission in hippocampal neurons via postsynaptic tyrosine kinase receptors. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 8074-8077
23. Li S.-C., Lindenberger U., and Sikstrom S. Aging cognition: from neuromodulation to representation. Trends Cogn. Sci. 5 (2001) 479-486
24. Linville D.G., and Arneric S.P. Cortical cerebral blood flow governed by the basal forebrain: age-related impairments. Neurobiol. Aging 12 (1991) 503-510
25. Masters C.L., Simms G., Weinman N.A., Multhaup G., McDonald B.L., and Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. U. S. A. 82 (1985) 4245-4249
26. Mattson M.P. Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol. Rev. 77 (1997) 1081-1132
27. Mendelson W., and Bergmann B. EEG delta power during sleep in young and old rats. Neurobiol. Aging 20 (1999) 669-673
28. Moyanova S., Kirov R., and Kortenska L. Age-related changes in neocortical high-voltage spindles and alpha EEG power during quiet waking in rats. Int. J. Neurosci. 1112 (2002) 473-487
29. Nitsch R.M., Slack B.E., Wurtman R.J., and Growdon J.H. Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science 258 (1992) 304-307
30. Niwa K., Younkin L., Ebeling C., Turner S.K., Westaway D., Younkin S., Hsiao Ashe K., Carlson G.A., and Iadecola C. Aβ1-40 related reduction in functional hyperemia in mouse neocortex during somatosensory activation. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 9735-9740
31. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1997), Academic Press, San Diego
32. Roch J.M., Masliah E., Roch-Levecq A.C., Sundsmo M.P., Otero D.A., Veinbergs I., and Saitoh T. Increase of synaptic density and memory retention by a peptide representing the trophic domain of the amyloid beta/A4 protein precursor. Proc. Natl. Acad. Sci. 91 (1994) 7450-7454
33. Sebban C., Zhang X., Tesolin-Decros B., Millan M., and Speeding M. Changes in EEG spectral power in the prefrontal cortex of conscious rats elicited by drugs interacting with dopaminergic and noradrenergic transmission. Br. J. Pharmacol. 128 (1999) 1045-1054
34. Seo H., Ferree A., and Isacson O. Cortico-hippocampal APP and NGF levels are dynamically altered by cholinergic muscarinic antagonist or M1 agonist treatment in normal mice. Eur. J. Neurosci. 15 (2002) 498-506
35. Steriade M., Amzica F., and Nunez A. Cholinergic and noradrenergic modulation of the slow (≈ 0.3 Hz) oscillations in neocortical cells. J. Neurophysiol. 70 (1993) 1385-1400
36. Steriade M., McCormick D.A., and Sejnowski T.J. Thalamocortical oscillations in the sleeping and aroused brain. Science 262 (1993) 679-685
37. Steriade M., Nunez A., and Amzica F. Intracellular analysis of relations between the slow (< 1 Hz) neocortical oscillations and other sleep rhythms of the electroencephalogram. J. Neurosci. 13 (1993) 3266-3283
38. Turner P., O'Conner K., Tate W., and Abraham W. Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory. Prog. Neurobiol. 70 (2003) 1-32
39. Wu C.-F., Bertorelli R., Sacconi M., Pepeu G., and Consolo S. Decrease of brain acetylcholine release in aging freely-moving rats detected by microdialysis. Neurobiol. Aging 9 (1988) 357-361